Genetic alterations in primary mediastinal B-cell lymphoma: an update.
Primary mediastinal B-cell lymphoma (PMBL) is a distinct clinical entity among non-Hodgkin's lymphoma. The malignancy has received little attention from a standpoint of basic research due in part to its rarity. However, based on recent studies consistent trends are beginning to emerge regarding the molecular and chromosomal alterations commonly observed in this disease. By both CGH and AP-PCR, genetic gains involving chromosomes 2, 5, 7, 9p, 12, and Xq are among the most frequently observed events. From a molecular standpoint, alterations in the c-myc, p16(INK4) and p53 genes have been observed in up to 30% of cases. This information along with the well-established histological, immunological, and clinical features should convince the few remaining disbelievers that PMBL is a distinct pathological entity among non-Hodgkin's lymphomas.
Scarpa
A
A
Department of Pathology-Section of Anatomical Pathology, Università di Verona, Italy. scarpa@anpat.univr.it
Moore
P S
PS
Rigaud
G
G
Menestrina
F
F
D002869:Chromosome Aberrations / Q000175:diagnosis; D025063:Chromosome Disorders; D006801:Humans; D016393:Lymphoma, B-Cell / Q000145:classification / Q000209:etiology / Q000235:genetics*; D008479:Mediastinal Neoplasms / Q000145:classification / Q000209:etiology / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics / Q000502:physiology
D009363:Neoplasm Proteins